Group leader
A study by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), the Universidad Complutense (UCM), Universidad de Girona (UdG), and the Institute for Bioengineering of Catalonia (IBEC), working together with other international centers, has overcome one of the key hurdles to the use of nanorobots powered by enzymes called lipases.
The called LipoBots, which could be used for medical applications. LipoBots are capable to self-propulsate and to retain their enzymatic functionality in conditions similar to those of the human stomach.
In a recent paper led by Ulm University in Germany and co-authored and co-led by Demestre, researchers describe the effect of SHANK3 protein on muscle tissues of patients with autism disorder.
The research was led by Jan van Hest and Laoi Abdelmohsen from the Institute of Complex Molecular Systems at TU/e in collaboration with Samuel Sánchez from the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, as well as researchers based in China and the UK.
Samuel Sánchez, Group Leader at the Institute for Bioengineering of Catalonia (IBEC) co-authored this piece, alongside world-renowned experts in bioengineering and cell synthesis.
An international committee has elected Samuel Sánchez, the European referent in nanomotors, as one of the new 13 researchers, among 185 candidates, who will be a member of the Young Academy of Spain.Last Thursday, May 28, the General Board of the Young Academy of Spain elected 13 new academic members. An independent international committee composed of highly prestigious researchers from different areas of knowledge participated in the selection process.
Alex’s work, entitled ‘The secret of oncological medicine hidden in the nanoworld’, is one of the 25 school research projects tutored last year by IBEC researchers.
An international committee has elected Samuel Sánchez, the European referent in nanomotors, as one of the new 13 researchers, among 185 candidates, who will be a member of the Young Academy of Spain.